SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS

Authors :: Ulrich Mey
K. Eckhardt
Francesco Bertoni
D. Kienle
Christiane Pott
Fatime Krasniqi
Emanuele Zucca
Urban Novak
Sämi Schär
Davide Rossi
N. Mach
Anastasios Stathis
Dagmar Hess
Karin Hohloch
Christian Schmidt
Christian Buske
Alden A. Moccia
Felicitas Hitz
Stefanie Hayoz
Michael Unterhalt
Stefan Dirnhofer
Wolfgang Hiddemann
Luca Ceriani
Source :: Hematological Oncology. 37:118-119
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Venetoclax
business.industry
Follicular lymphoma
Hematology
General Medicine
medicine.disease
chemistry.chemical_compound
chemistry
Obinutuzumab
Internal medicine
medicine
business

Full Text Access

Tools